Abiopharma

QuidelOrtho Corporation - QuidelOrtho China Volume-Based Procurement– Current Considerations

Erasca Announces Pricing of Upsized Public Offering of Common Stock

CORT INVESTIGATION ALERT: Investigation Launched into Corcept Therapeutics (CORT), Hagens Berman Encourages Investors to Contact Firm

ResMed Inc. Daily Stock Update

Aurora Cannabis to Host Third Quarter 2026 Investor Conference Call

Gilead - New England Journal of Medicine Publishes Phase 3 ASCENT-04/KEYNOTE-D19 Results SupportingTrodelvy® Plus Keytruda® as a Potential New Standard of Care in First-line PD-L1+ Metastatic Triple-negative Breast Cancer

Baxter - Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors

Aptar - Aptar Again Recognized with Prestigious‘A’ Score on the CDP Climate Change Assessment

New Form PREM14A - AMICUS THERAPEUTICS, INC. Filed: 2026-01-21 AccNo: 0001140361-26-001852 Size: 5 MB

Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, January 22, 2026 at 9:00 A.M. ET

Axogen Announces Proposed Public Offering of Common Stock

Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026

AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions

Madrigal Pharmaceuticals Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(c)(4)

Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast